Identity
- Security key
- 12167
- Ticker
- AYTU
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2008-02-15
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- AYTU
Detail
Enriched 2026-08-14 20:47
- Market cap
- $25,330,370.88
- Shares outstanding (class)
- 10,733,208
- Shares outstanding (weighted)
- 10,733,208
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 83
- Location
- DENVER, CO
- Homepage
- https://www.aytubio.com
- Description
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Market cap and share counts drift.